The 3EO Health COVID-19 Test is a single-use molecular in vitro diagnostic test intended for the qualitative detection of SARS CoV-2 nucleic acid directly in anterior nasal swab specimens from individuals with signs and symptoms of COVID-19 (i.e., symptomatic).
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult-collected anterior nasal (nares) swab samples from individuals aged two years or older.
This test utilizes nucleic acid amplification technology, similar to PCR, for the detection of SARS-CoV-2 RNA, which is generally detectable in anterior nasal swab samples during the acute phase of infection.
